Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Albumin-Bound Paclitaxel × 30 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Breast Neoplasms 4 Neoplasm Metastasis 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Pancreatic Ductal 2 Recurrence 1 Oropharyngeal Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms 1 Mouth Neoplasms 1 Metastatic Adenocarcinoma of the Pancreas 1 Lip Neoplasms 1 Laryngeal Neoplasms 1 Gastric Adenocarcinoma 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma 1 Biliary Tract Neoplasms 1 Anus Neoplasms 1

Interventions

trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 dabrafenib 1 Whole-Body Irradiation 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Immunotherapy 1 Gemcitabine 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Biopsy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡